[在多发性硬化症中高疾病活性的理论方法和预后意义]
1Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet, Eger.
概括
多发性硬化症 (MS) 是一种中枢神经系统自身免疫性疾病. 监测疾病活动对于预后和指导患者有效治疗决策至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 多发性硬化症 (MS) 涉及中枢神经系统脱髓化和神经退行.
- 慢性炎症,存在于疾病发作,驱动轴突退化和MS进展.
- 疾病活动是关键的预后因素,决定了治疗选择.
研究的目的:
- 强调评估和持续监测多发性硬化症疾病活动的重要性.
- 突出疾病活性在确定疾病修饰疗法需求中的作用.
- 根据检测到的活性,强调启动或切换到高效疗法的必要性.
主要方法:
- 疾病活动的临床评估.
- 对疾病进展进行放射性监测.
- 遵守治疗决策的专业指南.
主要成果:
- 疾病活动是MS的明确预后因素.
- 临床和放射学活动的持续监测为治疗策略提供了信息.
- 早期发现活性需要立即启动或调整治疗.
结论:
- 确定和监测多发性硬化症疾病活动对于患者管理至关重要.
- 根据疾病活动指导的及时治疗干预对于改善结果至关重要.
- 遵守指南可确保为管理多发性硬化症进展提供最佳治疗选择.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20


